23 September, 2024 | News
Accurate identification of disease-causing genetic alterations is crucial for refining the diagnosis and treatment of blood cancers. The broad gene panel for myeloid malignancies, a subset of blood cancers, developed by Genomic Medicine Sweden in collaboration with...
20 May, 2024 | Press release
Today, the Swedish Ministry of Social Affairs announces that it is granting SEK 49.5 million to Genomic Medicine Sweden (GMS) to develop and intensify work in precision diagnostics, childhood cancer, rare diseases and data sharing. “This extensive investment...